Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Free Cash Flow (2023 - 2025)

Historic Free Cash Flow for Camp4 Therapeutics (CAMP) over the last 3 years, with Q3 2025 value amounting to -$11.2 million.

  • Camp4 Therapeutics' Free Cash Flow fell 1572.27% to -$11.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$47.7 million, marking a year-over-year decrease of 265.93%. This contributed to the annual value of -$46.0 million for FY2024, which is 269.44% down from last year.
  • According to the latest figures from Q3 2025, Camp4 Therapeutics' Free Cash Flow is -$11.2 million, which was down 1572.27% from -$10.3 million recorded in Q2 2025.
  • Over the past 5 years, Camp4 Therapeutics' Free Cash Flow peaked at -$9.7 million during Q3 2024, and registered a low of -$14.6 million during Q1 2025.
  • For the 3-year period, Camp4 Therapeutics' Free Cash Flow averaged around -$11.8 million, with its median value being -$11.4 million (2024).
  • Data for Camp4 Therapeutics' Free Cash Flow shows a peak YoY increase of 2329.0% (in 2025) and a maximum YoY decrease of 2908.62% (in 2025) over the last 5 years.
  • Quarter analysis of 3 years shows Camp4 Therapeutics' Free Cash Flow stood at -$12.0 million in 2023, then rose by 3.63% to -$11.6 million in 2024, then grew by 3.21% to -$11.2 million in 2025.
  • Its last three reported values are -$11.2 million in Q3 2025, -$10.3 million for Q2 2025, and -$14.6 million during Q1 2025.